Literature DB >> 27115249

Chemical Tools To Monitor and Manipulate Adaptive Immune Responses.

Todd M Doran1, Mohosin Sarkar1, Thomas Kodadek1.   

Abstract

Methods to monitor and manipulate the immune system are of enormous clinical interest. For example, the development of vaccines represents one of the earliest and greatest accomplishments of the biomedical research enterprise. More recently, drugs capable of "reawakening" the immune system to cancer have generated enormous excitement. But, much remains to be done. All drugs available today that manipulate the immune system cannot distinguish between "good" and "bad" immune responses and thus drive general and systemic immune suppression or activation. Indeed, with the notable exception of vaccines, our ability to monitor and manipulate antigen-specific immune responses is in its infancy. Achieving this finer level of control would be highly desirable. For example, it might allow the pharmacological editing of pathogenic immune responses without restricting the ability of the immune system to defend against infection. On the diagnostic side, a method to comprehensively monitor the circulating, antigen-specific antibody population could provide a treasure trove of clinically useful biomarkers, since many diseases expose the immune system to characteristic molecules that are deemed foreign and elicit the production of antibodies against them. This Perspective will discuss the state-of-the-art of this area with a focus on what we consider seminal opportunities for the chemistry community to contribute to this important field.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27115249      PMCID: PMC5332222          DOI: 10.1021/jacs.6b02954

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  119 in total

Review 1.  Selecting chemicals: the emerging utility of DNA-encoded libraries.

Authors:  Matthew A Clark
Journal:  Curr Opin Chem Biol       Date:  2010-03-26       Impact factor: 8.822

2.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

Review 3.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

Review 4.  Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system.

Authors:  Yago Pico de Coaña; Aniruddha Choudhury; Rolf Kiessling
Journal:  Trends Mol Med       Date:  2015-06-16       Impact factor: 11.951

5.  Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes.

Authors:  E Bonifacio; V Lampasona; L Bernasconi; A G Ziegler
Journal:  Diabetes       Date:  2000-02       Impact factor: 9.461

6.  A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.

Authors:  Bo Zhang; Rajiv B Kumar; Hongjie Dai; Brian J Feldman
Journal:  Nat Med       Date:  2014-07-13       Impact factor: 53.440

7.  Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.

Authors:  J Kim; W Richter; H J Aanstoot; Y Shi; Q Fu; R Rajotte; G Warnock; S Baekkeskov
Journal:  Diabetes       Date:  1993-12       Impact factor: 9.461

8.  A liquid array platform for the multiplexed analysis of synthetic molecule-protein interactions.

Authors:  Todd M Doran; Thomas Kodadek
Journal:  ACS Chem Biol       Date:  2013-11-20       Impact factor: 5.100

9.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

Review 10.  Recent advances of protein microarrays.

Authors:  Claus Hultschig; Jürgen Kreutzberger; Harald Seitz; Zoltán Konthur; Konrad Büssow; Hans Lehrach
Journal:  Curr Opin Chem Biol       Date:  2005-12-22       Impact factor: 8.822

View more
  5 in total

1.  Screening one bead one compound libraries against serum using a flow cytometer: Determination of the minimum antibody concentration required for ligand discovery.

Authors:  Osayemwenre Erharuyi; Scott Simanski; Patrick J McEnaney; Thomas Kodadek
Journal:  Bioorg Med Chem Lett       Date:  2018-01-31       Impact factor: 2.823

2.  Structural characterization of a peptoid-inspired conformationally constrained oligomer (PICCO) bound to streptavidin.

Authors:  Patrick McEnaney; Madeline Balzarini; Hajeung Park; Thomas Kodadek
Journal:  Chem Commun (Camb)       Date:  2020-08-12       Impact factor: 6.222

Review 3.  Recent advances on smart glycoconjugate vaccines in infections and cancer.

Authors:  Marko Anderluh; Francesco Berti; Anna Bzducha-Wróbel; Fabrizio Chiodo; Cinzia Colombo; Federica Compostella; Katarzyna Durlik; Xhenti Ferhati; Rikard Holmdahl; Dragana Jovanovic; Wieslaw Kaca; Luigi Lay; Milena Marinovic-Cincovic; Marco Marradi; Musa Ozil; Laura Polito; Josè Juan Reina; Celso A Reis; Robert Sackstein; Alba Silipo; Urban Švajger; Ondřej Vaněk; Fumiichiro Yamamoto; Barbara Richichi; Sandra J van Vliet
Journal:  FEBS J       Date:  2021-06-01       Impact factor: 5.622

4.  Epitope alteration by small molecules and applications in drug discovery.

Authors:  Biyue Zhu; Jing Yang; Richard Van; Fan Yang; Yue Yu; Astra Yu; Kathleen Ran; Keyi Yin; Yingxia Liang; Xunuo Shen; Wei Yin; Se Hoon Choi; Ying Lu; Changning Wang; Yihan Shao; Liang Shi; Rudolph E Tanzi; Can Zhang; Yan Cheng; Zhirong Zhang; Chongzhao Ran
Journal:  Chem Sci       Date:  2022-06-28       Impact factor: 9.969

5.  Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies.

Authors:  Haofei Hong; Zhifang Zhou; Kun Zhou; Shaozhong Liu; Zhongwu Guo; Zhimeng Wu
Journal:  Chem Sci       Date:  2019-08-28       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.